After clinical trials at Beijing Fuwai Hospital, Beijing Jishuitan Hospital, and Henan Cancer Hospital, Yi Feng has been validated for use in mechanical hemostasis of the sternotomy incision in cardiac surgery and bone surfaces in the limbs, spine, and pelvis in orthopedic oncology. Data show that its safety and efficacy meet expectations. It is highly moldable, easy to use, and does not require any changes to the surgeon's established practices.